GlassScriptPhysician profile
Michael Iloanya
NPI 1407350184
$3,704.33
in general payments reported to CMS, 2019-2025
11 companies · $2,504 in 2025
The $2,504 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.40 · 2022: $453 · 2023: $193 · 2024: $505 · 2025: $2,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735 · Travel and Lodging: $1,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.41 |
| Travel and Lodging | $1,466.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,817.22 | 2025 | Na, Motoband |
| Stryker Corporation | $711.88 | 2022-2025 | Gamma, Axsos, Aequalis Ascend Flex |
| Medtronic, INC. | $321.18 | 2021-2022 | |
| Treace Medical Concepts, INC. | $206.19 | 2025 | |
| Depuy Synthes Sales INC. | $193.17 | 2024-2025 | Na, Fibergraft Aeridyan Matrix |
| Bone Support INC. | $144.39 | 2025 | Cerament G, Ceramentbone Void Filler |
| Coastal Medical Technologies LLC | $130.79 | 2025 | |
| Convatec INC. | $95.84 | 2023 | |
| Globus Medical, INC. | $31.93 | 2025 | Autobahn |
| Innovation Technologies INC | $25.94 | 2024 | Irrisept |
| Medacta USA, INC. | $25.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Iloanya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.